Trade VERA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vera Therapeutics, Inc. Class A (VERA) is trading at US$31.77, down 5.64% today as of Sep 16, 16:00 EDT. The company has a market capitalisation of US$2.33B. Over the past 52 weeks, VERA has traded between US$23.05 and US$56.05. On Syfe you can trade VERA with $0 commission and add it to your watchlist.
| Previous close | US$33.67 |
|---|---|
| Market cap | US$2.33B |
| 52-week range | US$23.05 – US$56.05 |
| Volume | 3.91M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vera Therapeutics, Inc. Class A
Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.
Year: 2021
Vera Therapeutics, Inc. Class A (VERA) stock is trading at US$31.77, -5.64% from the previous close of US$33.67.
The market cap for Vera Therapeutics, Inc. Class A (VERA) stock is approximately US$2.33B.
The 52-week high for Vera Therapeutics, Inc. Class A (VERA) stock is US$56.05.
The 52-week low for Vera Therapeutics, Inc. Class A (VERA) stock is US$23.05.
Vera Therapeutics, Inc. Class A (VERA) does not currently pay a dividend.
Stay on top of VERA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
